Universal hospital admission screening for carbapenemase-producing organisms in a low-prevalence setting.
about
A Decade of Development of Chromogenic Culture Media for Clinical Microbiology in an Era of Molecular Diagnostics.Clinical sensitivity and specificity of the Check-Points Check-Direct ESBL Screen for BD MAX, a real-time PCR for direct ESBL detection from rectal swabs.Audit of the management of patients at high risk of carbapenemase-producing enterobacteriaceae (CPE): Are we ready?Fast and expensive (PCR) or cheap and slow (culture)? A mathematical modelling study to explore screening for carbapenem resistance in UK hospitals
P2860
Universal hospital admission screening for carbapenemase-producing organisms in a low-prevalence setting.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Universal hospital admission s ...... s in a low-prevalence setting.
@en
type
label
Universal hospital admission s ...... s in a low-prevalence setting.
@en
prefLabel
Universal hospital admission s ...... s in a low-prevalence setting.
@en
P2093
P2860
P356
P1476
Universal hospital admission s ...... s in a low-prevalence setting.
@en
P2093
Amita Patel
Antonio Querol-Rubiera
Chioma Ahanonu
Eleonora Dyakova
Jonathan A Otter
Jonathan D Edgeworth
Karen N Bisnauthsing
Olga Tosas Auguet
P2860
P304
P356
10.1093/JAC/DKW309
P407
P577
2016-08-11T00:00:00Z